| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SCP |
| Uniprot No | P89458 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-112aa |
| 氨基酸序列 | MAAPQFHRPSTITADNVRALGMRGLVLATNNAQFIMDNSYPHPHGTQGAVREFLRGQAAALTDLGVTHANNTFAPQPMFAGDAAAEWLRPSFGLKRTYSPFVVRDPKTPSTP |
| 预测分子量 | 19.1 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3条关于SCP重组蛋白的示例参考文献(注：文献为虚构示例，仅用于格式展示)：
---
1. **文献名称**：Structural Characterization of SCP-2 Recombinant Protein in Lipid Metabolism
**作者**：Zhang, L. et al.
**摘要**：通过大肠杆菌表达系统成功重组表达SCP-2蛋白，利用X射线晶体学解析其三维结构，揭示其与脂肪酸结合的活性位点，为研究其在脂质代谢中的调控机制提供结构基础。
---
2. **文献名称**：Functional Analysis of SCP Recombinant Proteins in Antiviral Immunity
**作者**：Kim, J.H. & Patel, R.
**摘要**：研究SCP重组蛋白(SCP-3)在昆虫细胞中的表达及其对RNA病毒感染的抑制作用，发现其通过激活宿主天然免疫通路增强抗病毒反应，为新型抗病毒药物开发提供候选分子。
---
3. **文献名称**：High-Yield Purification and Biomedical Application of SCP-1 Recombinant Protein
**作者**：Gomez, M.A. et al.
**摘要**：开发了一种基于亲和层析的高效SCP-1重组蛋白纯化工艺，验证其在体外模型中促进干细胞分化的功能，并评估其作为组织工程支架材料的潜力。
---
注：实际文献需通过PubMed、Web of Science等数据库检索真实研究。
**Background of SCP Recombinant Proteins**
Recombinant proteins, engineered through genetic modification, are pivotal in biotechnology, medicine, and research. SCP (Synthetic Cell-based Protein) recombinant proteins represent a specialized class produced using advanced synthetic biology platforms. These proteins are synthesized by integrating target genes into host organisms (e.g., bacteria, yeast, mammalian cells), which then express the desired protein via cellular machinery. This method overcomes limitations of traditional protein extraction from natural sources, enabling scalable, cost-effective production with high purity.
The development of SCP recombinant proteins accelerated with breakthroughs in genetic engineering, such as CRISPR and plasmid vector design, allowing precise control over protein expression. Applications span therapeutics (e.g., insulin, monoclonal antibodies), industrial enzymes, and research tools (e.g., fluorescent tags). SCP systems are particularly valued for their flexibility; hosts can be tailored for post-translational modifications (e.g., glycosylation in mammalian cells) critical for protein functionality.
Challenges include optimizing expression yields, ensuring proper protein folding, and minimizing host-induced contaminants. Innovations like AI-driven strain optimization and high-throughput screening address these issues. Additionally, SCP platforms align with sustainable practices by reducing reliance on animal-derived components.
Ethical and safety considerations persist, particularly regarding genetically modified organisms (GMOs) and allergenicity. Regulatory frameworks ensure rigorous quality control. As synthetic biology evolves, SCP recombinant proteins are poised to revolutionize personalized medicine, vaccine development, and biomanufacturing, underscoring their transformative role in science and industry.
(Word count: 236)
×
